letrozole stada film coated tablet 2.5mg
dch auriga singapore - letrozole - tablet, film coated - letrozole 2.5mg
letrozole 2.5mg film-coated tablets film-coated tablets
accord healthcare polska sp. z o.o. - letrozole - film-coated tablets - 2,5mg
letrozole 2.5mg film-coated tablets film-coated tablets
accord healthcare polska sp. z o.o. - letrozole - film-coated tablets - 2,5mg
cipla letrozole letrozole 2.5mg film-coated tablet blister pack
cipla australia pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400 - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
accozole letrozole 2.5 mg film-coated tablet blister pack
arrotex pharmaceuticals pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; sodium starch glycollate type a; maize starch; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - indicated for the treatment of post menopausal women with hormone receptor positive breast cancer. the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
gynotril letrozole 2.5 mg tablet blister pack
strides pharma science pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; maize starch; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of postmenopausal women with hormone receptor positive breast cancer (see "clinical trials"). the safety and efficacy of neoadjuvant use has not been established. letrozole is not indicated in hormone receptor negative disease.
letrozole 2.5 milligram film coated tablet
flynn pharma ltd - letrozole - film coated tablet - 2.5 milligram
nolvadex d 20 mg film-coated tablets
astrazeneca uk limited - tamoxifen citrate - film-coated tablet - 20 milligram(s) - anti-estrogens; tamoxifen
tamoxifen 10mg film-coated tablets
wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - tamoxifen - film-coated tablet - tamoxifen 10 mg - endocrine therapy
tamoxifen 20mg film-coated tablets
wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - tamoxifen - film-coated tablet - tamoxifen 20 mg - endocrine therapy